% | $
Quotes you view appear here for quick access.


  • corruptbusinesss corruptbusinesss Nov 16, 2012 4:32 PM Flag

    We should re-visit the low next week

    We'll see how low this is going but at this level if they would happen to settle litigation one might think we could break .06 pretty easily when or if they dump those millions of shares in quick order. Man this stock is only fit for the trash bin. An investor needs to have an iron stomach to stay with this stock or maybe just needs to be very gullible.

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • No reason it should trade above .04. That's where it was pre-FDA trial approval, and the company still is years away from the first penny of revenue from any kind of stem therapy. Big money knows how many years it takes to actual application, that's why they have not invested a dime in actc. Pre-FDA there were zero revenues, today there are zero revenues. The only difference is that now actc is in the very earliest phase/timeline of FDA approved trials, and that don't mean squat to the market since it takes years to market a therapy if no one else beats actc to the endline (like, STEM, or the many other trials recently approved that may or may not have anything to do with stem cells, but are targeting AMD and SMD).

    • We hope just an iron stomach!